Page last updated: 2024-09-04
ly 311727 and thromboxane b2
ly 311727 has been researched along with thromboxane b2 in 1 studies
Compound Research Comparison
| Studies (ly 311727) | Trials (ly 311727) | Recent Studies (post-2010) (ly 311727) | Studies (thromboxane b2) | Trials (thromboxane b2) | Recent Studies (post-2010) (thromboxane b2) |
|---|---|---|---|---|---|
| 33 | 1 | 6 | 7,483 | 715 | 485 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Armstrong, CT; Bach, NJ; Bobbitt, JL; Dillard, RD; Draheim, S; Fleisch, JH; Fouts, R; Jackson, WT; Martinelli, M; Mihelich, ED; Roman, CR; Snyder, DW; Spaethe, SM | 1 |
Other Studies
1 other study(ies) available for ly 311727 and thromboxane b2
| Article | Year |
|---|---|
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.
Topics: Animals; Arachidonic Acid; Bronchoalveolar Lavage; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guinea Pigs; Humans; Indoles; Male; Phospholipases A; Phospholipases A2; Thromboxane A2; Thromboxane B2 | 1996 |